rs200386096
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_152383.5(DIS3L2):c.1727G>A(p.Arg576His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,613,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_152383.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIS3L2 | NM_152383.5 | c.1727G>A | p.Arg576His | missense_variant | 14/21 | ENST00000325385.12 | NP_689596.4 | |
DIS3L2 | NM_001257281.2 | c.1581+36745G>A | intron_variant | NP_001244210.1 | ||||
DIS3L2 | NR_046476.2 | n.1873G>A | non_coding_transcript_exon_variant | 14/21 | ||||
DIS3L2 | NR_046477.2 | n.1849G>A | non_coding_transcript_exon_variant | 13/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIS3L2 | ENST00000325385.12 | c.1727G>A | p.Arg576His | missense_variant | 14/21 | 5 | NM_152383.5 | ENSP00000315569.7 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000141 AC: 35AN: 249014Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 135086
GnomAD4 exome AF: 0.000188 AC: 275AN: 1461296Hom.: 0 Cov.: 30 AF XY: 0.000190 AC XY: 138AN XY: 726896
GnomAD4 genome AF: 0.000112 AC: 17AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74462
ClinVar
Submissions by phenotype
Perlman syndrome Uncertain:5Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 29, 2021 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital Bonn | Nov 25, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 30, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 576 of the DIS3L2 protein (p.Arg576His). This variant is present in population databases (rs200386096, gnomAD 0.03%). This missense change has been observed in individual(s) with sporadic Wilm's tumor (PMID: 22306653). ClinVar contains an entry for this variant (Variation ID: 410737). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DIS3L2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely benign, criteria provided, single submitter | clinical testing | 3billion | Sep 20, 2024 | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. - |
not provided Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The DIS3L2 p.R576H variant was identified in the literature as a heterozygous variant in a sporadic Wilms tumor and was not found in >200 control samples; when this variant was expressed in stably transfected HEK293 cells, it did not suppress anchorage-independent cell growth (Astuti_2012_PMID:22306653). The variant was identified in dbSNP (ID: rs200386096) and ClinVar (classified as uncertain significance by Fulgent Genetics and Invitae for Renal hamartomas nephroblastomatosis and fetal gigantism). The variant was identified in control databases in 36 of 265924 chromosomes at a frequency of 0.0001354 (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: Latino in 10 of 35026 chromosomes (freq: 0.000286), European (non-Finnish) in 19 of 117256 chromosomes (freq: 0.000162), Other in 1 of 6606 chromosomes (freq: 0.000151), South Asian in 4 of 30504 chromosomes (freq: 0.000131) and African in 2 of 22846 chromosomes (freq: 0.000088), but was not observed in the Ashkenazi Jewish, East Asian, or European (Finnish) populations. The p.R576 residue is conserved in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at